| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.15 | 0.02 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.02 |